In vitro activity of β-lactams and quinolones against AmpC β-lactamase-producing Escherichia coli-Reference-Cited by-同舟云学术

In vitro activity of β-lactams and quinolones against AmpC β-lactamase-producing Escherichia coli

Published:2005 Issue:1 Volume:11 Page:9-13
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Yamasaki Katsutoshi,Yamasaki Katsutoshi,Komatsu Masaru,Shimakawa Koichi,Satoh Kaori,Nishio Hisaaki,Sueyoshi Noriyuki,Toyokawa Masahiro,Sakamoto Masako,Higuchi Takeshi,Wada Yasunao,Kofuku Tomomi,Orita Tamaki,Yamashita Tomonari,Kinoshita Shohiro,Aihara Masanori

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Link

http://www.springerlink.com/index/pdf/10.1007/s10156-004-0352-0

Reference15 articles.

1. A functional classification scheme for β-lactamases and its correlation with molecular structure;Bush;Antimicrob Agents Chemother,1995

2. β-Lactamases in laboratory and clinical resistance;Livermore;Clin Microbiol Rev,1995

3. Cytosolic intermediates for cell wall biosynthesis and degradation control inducible β-lactam resistance in Gram-negative bacteria;Jacobs;Cell,1997

4. Induction of β-lactamase in Enterobacter cloacae;Wiedemann;Clin Infect Dis,1998

5. Inducible cephalosporinase production in clinical isolates of Enterobacter cloacae is controlled by a regulatory gene that has been deleted from Escherichia coli;Honoré;EMBO J,1986

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prulifloxacin: a review focusing on its use beyond respiratory and urinary tract infections;International Journal of Antimicrobial Agents;2011-04

2. Treatment of severe sepsis: where next? Current and future treatment approaches after the introduction of drotrecogin alfa;Vascular Health and Risk Management;2006-01